AIM
Allen Investment Management Portfolio holdings
AUM
$9.17B
This Quarter Return
+19.37%
1 Year Return
+26.06%
3 Year Return
+97.46%
5 Year Return
+146.63%
10 Year Return
+482.84%
AUM
$3.19B
AUM Growth
+$3.19B
(+29%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
49.48%
Holding
198
New
39
Increased
67
Reduced
39
Closed
7
Top Buys
| 1 |
Amazon
AMZN
|
$106M |
| 2 |
UnitedHealth
UNH
|
$87.9M |
| 3 |
Meta Platforms (Facebook)
META
|
$31.4M |
| 4 |
Booking.com
BKNG
|
$23M |
| 5 |
Comcast
CMCSA
|
$21.8M |
Top Sells
| 1 |
Equinix
EQIX
|
$33.1M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$31.9M |
| 3 |
Cencora
COR
|
$28.2M |
| 4 |
Sherwin-Williams
SHW
|
$21.3M |
| 5 |
Alerian MLP ETF
AMLP
|
$19.8M |
Sector Composition
| 1 | Consumer Discretionary | 23.12% |
| 2 | Communication Services | 21.11% |
| 3 | Technology | 10.41% |
| 4 | Healthcare | 10.38% |
| 5 | Consumer Staples | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Apollo Global Management
APO
$75.8B
| $1.17M | 0.04% |
41,305
+589
| +1% | +$16.6K |
|
102
iShares Russell 2000 ETF
IWM
$66.5B
| $1.07M | 0.03% |
+6,985
| New | +$1.07M |
|
103
Carlyle Group
CG
$23.1B
| $953K | 0.03% |
52,115
+843
| +2% | +$15.4K |
|
104
Invesco S&P 500 Pure Value ETF
RPV
$1.34B
| $951K | 0.03% |
15,073
| – | – |
|
105
Abbott
ABT
$229B
| $945K | 0.03% |
11,827
| – | – |
|
106
Merck
MRK
$212B
| $930K | 0.03% |
11,182
+7,348
| +192% | +$611K |
|
107
Boeing
BA
$176B
| $926K | 0.03% |
2,428
| – | – |
|
108
Intel
INTC
$105B
| $882K | 0.03% |
+16,433
| New | +$882K |
|
109
iShares MSCI EAFE ETF
EFA
$65.4B
| $870K | 0.03% |
13,414
| – | – |
|
110
Sony
SONY
$162B
| $852K | 0.03% |
20,172
+40
| +0.2% | +$1.69K |
|
111
Donaldson
DCI
$9.21B
| $801K | 0.03% |
16,000
| – | – |
|
112
iShares Russell 3000 ETF
IWV
$16.6B
| $801K | 0.03% |
4,807
+98
| +2% | +$16.3K |
|
113
iShares S&P 100 ETF
OEF
$22B
| $796K | 0.02% |
6,353
| – | – |
|
114
General Dynamics
GD
$86.7B
| $790K | 0.02% |
4,669
-205
| -4% | -$34.7K |
|
115
JD.com
JD
$44B
| $788K | 0.02% |
+26,130
| New | +$788K |
|
116
Dover
DOV
$24B
| $749K | 0.02% |
7,987
-1,684
| -17% | -$158K |
|
117
Neurocrine Biosciences
NBIX
$13.8B
| $718K | 0.02% |
+8,147
| New | +$718K |
|
118
Nektar Therapeutics
NKTR
$537M
| $718K | 0.02% |
+21,362
| New | +$718K |
|
119
AbbVie
ABBV
$376B
| $701K | 0.02% |
8,704
| – | – |
|
120
United Therapeutics
UTHR
$17.6B
| $695K | 0.02% |
+5,923
| New | +$695K |
|
121
PepsiCo
PEP
$203B
| $690K | 0.02% |
5,628
-1,667
| -23% | -$204K |
|
122
Pfizer
PFE
$141B
| $659K | 0.02% |
+15,521
| New | +$659K |
|
123
Cincinnati Financial
CINF
$23.9B
| $655K | 0.02% |
+7,622
| New | +$655K |
|
124
Vanguard S&P 500 ETF
VOO
$723B
| $647K | 0.02% |
2,493
+13
| +0.5% | +$3.37K |
|
125
iShares MSCI Emerging Markets ETF
EEM
$19B
| $624K | 0.02% |
14,549
| – | – |
|